Abstract: The present invention is related to 8-hydroxy-quinoline derivatives having multidrug-resistance reversing activity with improved selectivity and increased cytotoxicity towards multidrug-resistant cancer cells, preparation thereof and use of the same in the treatment of cancer, especially multidrug-resistant variants thereof.
Type:
Grant
Filed:
April 5, 2017
Date of Patent:
August 18, 2020
Assignee:
Magyar Tudományos Akadémia Természettudományi Kutatóközpont
Inventors:
Gergely Szakács, Tibor Soós, Roberta Ferenczi-Palkó, András Füredi, Szilárd Tóth, Dóra Türk, Veronika Pape, Ferenc Fülöp, István Szatmári, György Dormán
Abstract: The present invention is related to 8-hydroxy-quinoline derivatives having multidrug-resistance reversing activity with improved selectivity and increased cytotoxicity towards multidrug-resistant cancer cells, preparation thereof and use of the same in the treatment of cancer, especially multidrug-resistant variants thereof.
Type:
Application
Filed:
April 5, 2017
Publication date:
May 23, 2019
Applicant:
Magyar Tudományos Akadémia Természettudományi Kutatóközpont
Inventors:
Gergely SZAKÁCS, Tibor SOÓS, Roberta FERENCZI-PALKÓ, András FÜREDI, Szilárd TÓTH, Dóra TÜRK, Veronika PAPE, Ferenc FÜLÖP, István SZATMÁRI, György DORMÁN